Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedNov 13, 2019Basic Reset Nuovi Skin TonerMarketed without an Approved NDA/ANDABasic Reset Inc. · D-0189-2020Class IITerminatedNov 13, 2019Miracle Facelift MasqueMarketed without an Approved NDA/ANDABasic Reset Inc. · D-0188-2020Class IITerminatedNov 13, 2019Basic Reset Earth Wash Cleaner and Personal CareMarketed without an Approved NDA/ANDABasic Reset Inc. · D-0187-2020Class IITerminatedNov 13, 2019Alprazolam TabletsPresence of Foreign SubstanceMylan Pharmaceuticals Inc. · D-0186-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0185-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0184-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0183-2020Class IICompletedNov 13, 2019Dr. Reddy's Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0182-2020Class IICompletedNov 13, 2019Dr. Reddy's Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0181-2020Class IICompletedNov 13, 2019Dr. Reddy's Ranitidine CapsulesCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0180-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0179-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0178-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0177-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0176-2020Class IICompletedNov 13, 2019Ranitidine Tablets 75 mgCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0175-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0174-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0173-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0172-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0171-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0170-2020Class IICompletedNov 13, 2019Ranitidine TabletsCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0169-2020Class IICompletedNov 13, 2019Dr. Reddy's: Ranitidine Capsules 150 mgCGMP Deviations: Presence of NDMA impurity detected in product.Dr. Reddy's Laboratories, Inc. · D-0168-2020Class ITerminatedNov 6, 2019Mero Macho Artificially Flavored Passion Fruit Vitamin C Liquid SupplementMarketed without an approved NDA/ANDA: Product found to be tainted with Tadalafil.Fitoterapia USA, Inc · D-0320-2020Class IITerminatedNov 6, 2019Children's Ibuprofen Oral Suspension USPPresence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.Taro Pharmaceuticals U.S.A., Inc. · D-0302-2020Class IITerminatedNov 6, 2019Children's Ibuprofen Oral Suspension USPPresence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.Taro Pharmaceuticals U.S.A., Inc. · D-0301-2020Class IITerminatedNov 6, 2019Children's Ibuprofen Oral Suspension USPPresence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.Taro Pharmaceuticals U.S.A., Inc. · D-0300-2020Class IITerminatedNov 6, 2019Ibuprofen Oral Suspension USPPresence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.Taro Pharmaceuticals U.S.A., Inc. · D-0299-2020Class IITerminatedNov 6, 2019Ibuprofen Oral Suspension USPPresence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.Taro Pharmaceuticals U.S.A., Inc. · D-0298-2020Class IIITerminatedNov 6, 2019Testosterone Cypionate InjectionLabeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose vials, found to contain shelf cartons labelled as...Arbor Pharmaceuticals Inc. · D-0167-2020Class IIIOngoingNov 6, 2019Ranitidine Tablets USPCGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.AuroMedics Pharma LLC · D-0166-2020Class IITerminatedNov 6, 2019AVKARE Ranitidine Hydrochloride Capsules 300 mg 500 CapsulesCGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in APIAVKARE Inc. · D-0165-2020Class IITerminatedNov 6, 2019AVKARE Ranitidine Hydrochloride Capsules 150 mg 500 CapsulesCGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in APIAVKARE Inc. · D-0164-2020Class IIITerminatedNov 6, 2019Gatifloxacin Ophthalmic Solution 0.5%Labeling: Incorrect or missing package insert.Sandoz Inc · D-0163-2020Class IIITerminatedNov 6, 2019Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic SuspensionLabeling: Incorrect or missing package insert.Sandoz Inc · D-0162-2020Class IIITerminatedNov 6, 2019Bimatoprost Ophthalmic Solution 0.03%Labeling: Incorrect or missing package insert.Sandoz Inc · D-0161-2020Class IITerminatedNov 6, 2019Lyophilized Human Chorionic Gonadotropin 5Lack of Sterility Assurance.Innoveix Pharmaceuticals Inc · D-0160-2020Class IITerminatedNov 6, 2019Lyophilized Sermorelin w/ GHRP2 3 mg For injectionLack of Sterility Assurance.Innoveix Pharmaceuticals Inc · D-0159-2020Class IITerminatedNov 6, 2019Lyophilized Human Chorionic Gonadotropin 5Lack of Sterility Assurance.Innoveix Pharmaceuticals Inc · D-0158-2020Class IITerminatedNov 6, 2019Lyophilized Chorionic Gonadotropin 11Lack of Sterility Assurance.Innoveix Pharmaceuticals Inc · D-0157-2020Class IITerminatedNov 6, 2019Estradiol Vaginal Inserts USPDefective Delivery System: complaints for difficulty in pushing the plunger of the applicator.Glenmark Pharmaceuticals Inc., USA · D-0156-2020